Skip to content

Clinical trials

Phase 1 Pathologic Processes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Phase: Phase 1 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20141
20151
20171
20181
20202
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Withdrawn2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capricor Inc.1
Corcept Therapeutics1
David M. Brown, M.D.1
Hutchmed1
Indiana University1
Meryx, Inc.1
NYU Langone Health1
Neurocrine Biosciences1
Tracon Pharmaceuticals Inc.1
University of Maryland, Baltimore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes11
Adrenal Gland Diseases2
Adrenocortical Hyperfunction2
Cardiovascular Diseases2
Endocrine System Diseases2
Ischemia2
Mental Disorders2
Neoplasms2
Neoplastic Processes2
Substance-Related Disorders2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.